CD44‐Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma-Reference-Cited by-同舟云学术

CD44‐Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma

Published:2019-09-27 Issue:46 Volume:31 Page:1904742
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Gu Wenxing¹²,An Jingnan³,Meng Hao¹,Yu Na¹,Zhong Yinan¹,Meng Fenghua¹,Xu Yang³,Cornelissen Jeroen J. L. M.²,Zhong Zhiyuan¹^ORCID

Affiliation:

1. Biomedical Polymers LaboratoryCollege of ChemistryChemical Engineering and Materials ScienceState Key Laboratory of Radiation Medicine and ProtectionSoochow University Suzhou 215123 P. R. China

2. Department of Biomolecular NanotechnologyMESA+ Institute for NanotechnologyUniversity of Twente 7500 AE Enschede The Netherlands

3. Jiangsu Institute of HematologyThe First Affiliated Hospital of Soochow UniversityInstitute of Blood and Marrow Transplantation of Soochow UniversityCollaborative Innovation Center of HematologySoochow University Suzhou 215123 P. R. China

Funder

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201904742

Reference47 articles.

1. Clinical cancer nanomedicine

2. Nanoparticle therapeutics: an emerging treatment modality for cancer